Camphausen K - Search Results

1

Radiation abscopal antitumor effect is mediated through p53.

Camphausen K, Moses MA, Ménard C, Sproull M, Beecken WD, Folkman J, O'Reilly MS. Camphausen K, et al. Cancer Res. 2003 Apr 15;63(8):1990-3. Cancer Res. 2003. PMID: 12702593

2

Radiation therapy to a primary tumor accelerates metastatic growth in mice.

Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Camphausen K, et al. Cancer Res. 2001 Mar 1;61(5):2207-11. Cancer Res. 2001. PMID: 11280788

3

Cancer. What does radiotherapy do to endothelial cells?

Folkman J, Camphausen K. Folkman J, et al. Among authors: camphausen k. Science. 2001 Jul 13;293(5528):227-8. doi: 10.1126/science.1062892. Science. 2001. PMID: 11452105 No abstract available.

4

Angiogenesis inhibitors and radiotherapy of primary tumours.

Camphausen K, Menard C. Camphausen K, et al. Expert Opin Biol Ther. 2002 Jun;2(5):477-81. doi: 10.1517/14712598.2.5.477. Expert Opin Biol Ther. 2002. PMID: 12079484 Review.

5

Antiangiogenic therapy through copper chelation.

Sproull M, Brechbiel M, Camphausen K. Sproull M, et al. Among authors: camphausen k. Expert Opin Ther Targets. 2003 Jun;7(3):405-9. doi: 10.1517/14728222.7.3.405. Expert Opin Ther Targets. 2003. PMID: 12783576 Review.

6

Evaluation of copper chelation agents as anti-angiogenic therapy.

Camphausen K, Sproull M, Tantama S, Sankineni S, Scott T, Ménard C, Coleman CN, Brechbiel MW. Camphausen K, et al. Bioorg Med Chem. 2003 Sep 15;11(19):4287-93. doi: 10.1016/s0968-0896(03)00401-2. Bioorg Med Chem. 2003. PMID: 12951159

7

Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.

Russell JS, Burgan W, Oswald KA, Camphausen K, Tofilon PJ. Russell JS, et al. Among authors: camphausen k. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3749-55. Clin Cancer Res. 2003. PMID: 14506167

8

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ. Russell JS, et al. Among authors: camphausen k. Cancer Res. 2003 Nov 1;63(21):7377-83. Cancer Res. 2003. PMID: 14612536

9

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results.

Ménard C, Camphausen K, Muanza T, Sears-Crouse N, Smith S, Ben-Josef E, Coleman CN. Ménard C, et al. Among authors: camphausen k. Semin Oncol. 2003 Dec;30(6 Suppl 18):63-7. doi: 10.1053/j.seminoncol.2003.11.016. Semin Oncol. 2003. PMID: 14727242 Clinical Trial.

10

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, Tofilon PJ. Camphausen K, et al. Cancer Res. 2004 Jan 1;64(1):316-21. doi: 10.1158/0008-5472.can-03-2630. Cancer Res. 2004. PMID: 14729640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters